Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ACHE | P22303 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7811284 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL30058349 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL29700602 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL199961 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL29464227 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL138533 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| Hydrochloric Acid SCHEMBL290288 | 0.97 | TSHR (0.47) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL29357701 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL4480 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL3127305 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116178305-B | Light-induced carbene precursor compound and application thereof | 南京大学 | 2024-10-22 | — | — | CN | claimed |
| CN-113036036-B | Preparation method and application of benzothiadiazole molecular ternary electric storage device | 苏州科技大学 | 2024-01-09 | — | — | CN | claimed |
| CN-110359097-B | Method for obtaining On-DNA aromatic hydrocarbon compound through Suzuki coupling reaction in construction of DNA coding compound library | 上海药明康德新药开发有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-110331447-B | Method for preparing On-DNA aryl alkyne compound in construction of DNA coding compound library | 上海药明康德新药开发有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114502558-A | Method for preparing activin receptor-like kinase inhibitors | 缆图药品公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113788824-A | Pyridine compound | 第一三共株式会社 | 2021-12-14 | — | — | CN | claimed |
| CN-110204695-B | Narrow-band receptor type conjugated polymer containing low polyethylene glycol side chain structure and preparation method and application thereof | 吉林大学 | 2021-02-26 | — | — | CN | claimed |
| CN-110606840-A | Method for producing 5-alkynylpyridine compound | 日产化学株式会社 | 2019-12-24 | — | — | CN | claimed |
| EP-1931655-A2 | A PROCESS FOR THE PREPARATION OF SARTAN DERIVATIVES AND INTERMEDIATES USEFUL IN SUCH PROCESS | KRKA, D.D., Novo Mesto (SI) | 2008-06-18 | — | — | EP | claimed |
| EP-1776345-A2 | A MULTICORE INDAZOLINONE LIBRARY | The University Court of the University of St. Andrews (GB) | 2007-04-25 | — | — | EP | claimed |
| WO-2005121096-A2 | A MULTICORE INDAZOLINONE LIBRARY | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2005-12-22 | — | — | WO | claimed |
| US-6939985-B1 | covalently coupling organic compounds by reacting an aromatic ring compound having a halogen or halogen-like substituent at a coupling position with a diboron derivative in the presence of a Group VIII metal catalyst and a base | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2005-09-06 | — | — | US | claimed |
| US-20020193604-A1 | Aryl borates | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-12-19 | — | — | US | claimed |
| EP-0986541-A4 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMW SCIENT IND RES ORG (AU) | 2002-08-14 | — | — | EP | claimed |
| US-20020032339-A1 | ARYL BORATES | BORON MOLECULAR LIMITED (AU) | 2002-03-14 | — | — | US | claimed |
| US-6294688-B1 | REACTING HYDROXY-PROTECTED EPOXIDE WITH FLUORINATED ALCOHOL IN PRESENCE OF PALLADIUM CATALYST TO PRODUCE ALCOHOL HAVING SAME STEREOCHEMISTRY AS STARTING MATERIAL | HOFFMAN-LA ROCHE INC. | 2001-09-25 | — | — | US | claimed |
| US-6291694-B1 | REACTING EPOXY-UNSATURATED ESTER COMPOUND WITH FLUORINATED ALCOHOL IN PRESENCE OF PALLADIUM CATALYST TO PRODUCE VITAMIN D ANALOG COMPOUND | HOFFMAN-LA ROCHE INC. | 2001-09-18 | — | — | US | claimed |
| EP-1078931-A2 | Process for the preparation of vitamin D analogues | F. HOFFMANN-LA ROCHE AG (CH) | 2001-02-28 | — | — | EP | claimed |
| EP-0986541-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2000-03-22 | — | — | EP | claimed |
| WO-1998045265-A1 | PROCESS FOR COVALENTLY COUPLING ORGANIC COMPOUNDS UTILIZING DIBORON DERIVATIVES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-10-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193604-A1 | Aryl borates | BRD4, ABL1, BRD3 | TSHR 2306/4885ACHE 2773/4885ALDH1A1 1148/4885 |
| US-20020032339-A1 | ARYL BORATES | TBCB, HAT1, UBE2B | TSHR 2491/4885ACHE 3810/4885ALDH1A1 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.